Zacks Research Forecasts McKesson’s Q2 Earnings (NYSE:MCK)

McKesson Co. (NYSE:MCK) – Equities researchers at Zacks Research reduced their Q2 2026 EPS estimates for shares of McKesson in a research note issued on Tuesday, October 22nd. Zacks Research analyst R. Department now forecasts that the company will earn $8.39 per share for the quarter, down from their prior forecast of $8.51. The consensus estimate for McKesson’s current full-year earnings is $32.07 per share. Zacks Research also issued estimates for McKesson’s FY2026 earnings at $35.05 EPS, Q1 2027 earnings at $8.03 EPS, Q2 2027 earnings at $9.04 EPS and FY2027 earnings at $40.21 EPS.

Other equities research analysts have also recently issued reports about the stock. Evercore ISI dropped their price target on shares of McKesson from $660.00 to $630.00 and set an “outperform” rating on the stock in a research report on Thursday, August 8th. Wells Fargo & Company reduced their target price on shares of McKesson from $576.00 to $535.00 and set an “equal weight” rating for the company in a report on Friday, September 13th. Baird R W cut McKesson from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 24th. Leerink Partners reduced their price objective on McKesson from $665.00 to $630.00 and set an “outperform” rating for the company in a research note on Monday, October 7th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on McKesson from $623.00 to $579.00 and set a “buy” rating on the stock in a research report on Wednesday, September 25th. Five investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, McKesson has an average rating of “Moderate Buy” and an average target price of $610.86.

McKesson Stock Performance

Shares of MCK stock opened at $507.41 on Friday. The stock has a market cap of $65.93 billion, a PE ratio of 22.67, a price-to-earnings-growth ratio of 1.17 and a beta of 0.44. The business’s fifty day moving average is $517.48 and its 200-day moving average is $551.05. McKesson has a 1 year low of $431.35 and a 1 year high of $637.51.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $7.88 EPS for the quarter, beating analysts’ consensus estimates of $7.21 by $0.67. The business had revenue of $79.28 billion for the quarter, compared to analyst estimates of $82.53 billion. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the business earned $7.27 earnings per share.

Institutional Investors Weigh In On McKesson

Several institutional investors and hedge funds have recently added to or reduced their stakes in MCK. LRI Investments LLC bought a new position in shares of McKesson in the first quarter valued at approximately $28,000. Register Financial Advisors LLC bought a new position in McKesson in the 1st quarter worth $29,000. Wolff Wiese Magana LLC lifted its position in McKesson by 742.9% during the 3rd quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock worth $29,000 after acquiring an additional 52 shares during the last quarter. ORG Wealth Partners LLC bought a new stake in McKesson during the third quarter valued at about $40,000. Finally, Carmichael Hill & Associates Inc. acquired a new stake in shares of McKesson in the second quarter valued at about $52,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at McKesson

In related news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction on Monday, August 5th. The shares were sold at an average price of $626.03, for a total value of $2,349,490.59. Following the completion of the sale, the chief executive officer now owns 82,339 shares of the company’s stock, valued at approximately $51,546,684.17. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.11% of the stock is currently owned by company insiders.

McKesson Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 1st. Shareholders of record on Monday, September 2nd were paid a $0.71 dividend. The ex-dividend date was Friday, August 30th. This is a boost from McKesson’s previous quarterly dividend of $0.62. This represents a $2.84 dividend on an annualized basis and a yield of 0.56%. McKesson’s payout ratio is 12.69%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.